World's Best Scientists 2026 revealed!
Neuropsychiatric Disease and Treatment
H-index 27

Neuropsychiatric Disease and Treatment

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 1550 67 85 16

Additional Metrics

Number of Best Scientists*: 285
Documents by Best Scientists*: 269
Top 100 Ranked Scientists*: 11
SCIMAGO H-index: 98
SCIMAGO SJR: 0.913
Impact Factor: 2.9

Overview

Top Research Topics at Neuropsychiatric Disease and Treatment?

The journal investigates areas of study like Psychiatry, Internal medicine, Depression (differential diagnoses), Schizophrenia and Clinical psychology. While the journal focused on Psychiatry, it was also able to explore topics like Disease and Pediatrics. Parkinson's disease is a primary topic of Disease research in it.

The journal explores topics in Internal medicine which can be helpful for research in disciplines like Major depressive disorder, Endocrinology, Gastroenterology and Cardiology. The work on Depression (differential diagnoses) presented in it focuses on Antidepressant in particular. Antipsychotic and Positive and Negative Syndrome Scale are all topics related to Schizophrenia research discussed.

Neuropsychiatric Disease and Treatment tackles topics on Adverse effect, which can potentially contribute to the wider field of Pharmacology.

  • Psychiatry (31.23%)
  • Internal medicine (27.13%)
  • Depression (differential diagnoses) (15.97%)

What are the most cited papers published in the journal?

  • The increasing burden of depression (622 citations)
  • Sleep deprivation: Impact on cognitive performance (475 citations)
  • Maturation of the adolescent brain (350 citations)

Research areas of the most cited articles at Neuropsychiatric Disease and Treatment:

The journal papers primarily focus on research topics in Psychiatry, Depression (differential diagnoses), Internal medicine, Disease and Pharmacology. The journal publications deal with Psychiatry in conjunction with Clinical psychology and similar fields in Cognition. While Internal medicine is the focus of the most cited articles, it also provides insights into the studies of Placebo, Oncology and Endocrinology.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Disease
  • Surgery

The previous edition focused in particular on these issues:

Internal medicine, Depression (differential diagnoses), Logistic regression, Clinical psychology and Anxiety are among the topics commonly tackled in the journal. The studies on Internal medicine discussed can also contribute to research in the domains of Gastroenterology, Cardiology, Endocrinology and Schizophrenia. Antipsychotic and Positive and Negative Syndrome Scale are all disciplines of Schizophrenia that connect with topics in In patient.

While Depression (differential diagnoses) is the focus of it, it also provided insights into the studies of Psychological intervention and Mental health. Logistic regression research in it involves the investigation of Odds ratio studies, all of which are linked to disciplines such as Confidence interval. The Clinical psychology study featured in it draws connections with the study of Cognition.

The most cited articles from the last journal are:

  • A Systematic Review and Meta-Analysis of Transcranial Direct Current Stimulation to Remediate Age-Related Cognitive Decline in Healthy Older Adults. (6 citations)
  • The Psychological Experience and Intervention in Post-Acute COVID-19 Inpatients (6 citations)
  • A Bidirectional View of Migraine and Diet Relationship (5 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Neuropsychiatric Disease and Treatment (based on the number of publications) are:

  • Norio Yasui-Furukori (42 papers) published 3 papers at the last edition the same number as at the previous edition,
  • Takeshi Inoue (27 papers) published 5 papers at the last edition, 1 less than at the previous edition,
  • Jan Prasko (26 papers) absent at the last edition,
  • Norio Sugawara (25 papers) published 1 paper at the last edition,
  • Serge Brand (22 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Neuropsychiatric Disease and Treatment (based on the number of publications) are:

  • Chang Gung University (60 papers) absent at the last edition,
  • Capital Medical University (60 papers) published 11 papers at the last edition, 3 less than at the previous edition,
  • Shanghai Jiao Tong University (52 papers) published 9 papers at the last edition, 1 more than at the previous edition,
  • Nanchang University (49 papers) published 5 papers at the last edition the same number as at the previous edition,
  • Central South University (47 papers) published 4 papers at the last edition, 7 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 14.92% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 16.73% were posted by at least one author from the top 10 institutions publishing in the journal. Another 13.15% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 11.95% of all publications and 58.17% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Educational Opportunities for Neuropsychiatric Disease and Treatment Research

If studying and researching Neuropsychiatric diseases and treatments interests you, enrolling in a quality program that focuses on these areas will ensure a solid theoretical and practical groundwork. Higher education institutes offer a variety of degrees where students have the opportunity to delve deeper into Psychiatry, Internal medicine, Depression, Schizophrenia, and Clinical psychology, among others. These subjects are a significant part of the Neuropsychiatric Disease and Treatment Journal's core investigative areas. For those based in Idaho, a number of accredited nursing schools offer competitive programs intertwining nursing with a focus on neuropsychiatric diseases. These programs blend traditional learning with hands-on experiences, allowing a better understanding of the complexities of various mental health disorders. Students can further refine their research capabilities and potentially contribute to renowned journals like Neuropsychiatric Disease and Treatment. Enrolling in such a program not only offers the chance to be a part of innovative research and learning but could also open doors to a fulfilling clinical practice career. Thus, striving for better understanding and improvement in neuropsychiatric care is a rewarding journey, both in terms of personal growth and societal impact.

Top Publications

  • Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment.

    Christoph U Correll;Christoph U Correll;Nina R Schooler

    (2020)
    518 Citations
  • Management of Treatment-Resistant Depression: Challenges and Strategies.

    Daphne Voineskos;Zafiris J Daskalakis;Zafiris J Daskalakis;Daniel M Blumberger;Daniel M Blumberger

    (2020)
    399 Citations
  • Alcohol and Dementia - What is the Link? A Systematic Review.

    Caspar Wiegmann;Inge Mick;Eva J Brandl;Andreas Heinz

    (2020)
    56 Citations
  • Efficacy of Vortioxetine on Anhedonia: Results from a Pooled Analysis of Short-Term Studies in Patients with Major Depressive Disorder.

    Roger S McIntyre;Henrik Loft;Michael Cronquist Christensen

    (2021)
    54 Citations
  • Advances in the Treatment of Chronic Insomnia: A Narrative Review of New Nonpharmacologic and Pharmacologic Therapies

    Russell Rosenberg;Leslie Citrome;Christopher L Drake

    (2021)
    46 Citations
  • Assessment of the Impact of Tardive Dyskinesia in Clinical Practice: Consensus Panel Recommendations.

    Richard Jackson;Matthew N Brams;Leslie Citrome;Amber R Hoberg

    (2021)
    45 Citations
  • Tardive Dyskinesia in Older Persons Taking Antipsychotics

    Leslie Citrome;Stuart H Isaacson;Danielle Larson;Daniel Kremens

    (2021)
    43 Citations
  • Implementing Measurement-Based Care for Depression: Practical Solutions for Psychiatrists and Primary Care Physicians.

    Ran Ha Hong;Jill K Murphy;Erin E Michalak;Trisha Chakrabarty

    (2021)
    34 Citations
  • HIV, HSV, SARS-CoV-2 and Ebola Share Long-Term Neuropsychiatric Sequelae

    (2022)
    33 Citations
  • Clinically Significant Changes in the 17- and 6-Item Hamilton Rating Scales for Depression: A STAR*D Report.

    Augustus John Rush;Augustus John Rush;Augustus John Rush;Charles South;Shailesh Jain;Raafae S Agha

    (2021)
    33 Citations

Related Online Degrees & Career Pathways

For those interested in healthcare careers related to studying Medicine in the USA, exploring online nursing degrees can be a practical step. Many students consider online BSN programs for non nurses as a fast track to enter the nursing field without prior nursing experience.

Once you have a Bachelor of Science in Nursing, advancing to become a Nurse Practitioner (NP) is a popular option. Understanding how long does it take to be a nurse practitioner can help you plan your educational journey effectively. Many accelerated paths allow students to complete their qualifications sooner than traditional routes.

Specializing in psychiatric nursing is another promising pathway. Reviewing the psychiatric NP salary by state can offer valuable insight into potential earnings across various regions, helping you make informed career decisions.

For registered nurses aiming to upgrade their qualifications, several accelerated BSN programs offer a concise route to earning a Bachelor of Science in Nursing in as little as six months, boosting career mobility and specialization options.

Best Scientists Contributing to This Journal

Recently Published Articles